ArticleArchives of dermatological research2025
Relationship between bullous pemphigoid and metabolic syndrome and its relevant traits: a bidirectional two-sample Mendelian randomization study.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Bullous pemphigoid (BP) is a chronic autoimmune subepidermal blistering disease, affecting mostly the elderly. Metabolic syndrome (MetS) is a set of metabolic disorders including obesity, hypertension, glucose intolerance, and dyslipidemia. Observational studies have revealed a correlation between BP and MetS with controversial results and the causal relationship needs to be clarified. In the study of BP and MetS, observational investigations are prone to be biased by confounding factors such as the use of corticosteroids or age. However, Mendelian randomization (MR) is less susceptible to confounding factors and reverse causality. In this study, we aimed to use two-sample MR to investigate the causal correlation between BP and MetS from a genetic perspective. We used genome-wide association study (GWAS) data of BP, MetS, and its relevant traits to perform the analysis. The relevant traits consisted of four aspects, including central obesity, hypertension, impaired glucose tolerance, and dyslipidemia. In the results, it demonstrated no causal association of BP on the risk of MetS or its relevant traits and it revealed no significant linkage in the reverse procedure. This analysis enriched the research on the association of BP and MetS and provided evidence from a genetic perspective.
Indexed as
Identifiers
39760936What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.